Found 67 matching trials
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial tests how well giving dasatinib and quercetin with cycl...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma PHASE1 This study is a single-center, open Phase I study, to observe the effective...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT PHASE2 This is a prospective study comparing autologous hematopoietic stem cell tr...
Show More Location
The Affiliated Hospital oh Xuzhou Medical University
Learn More & Join Trial
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease PHASE2 The goal of this clinical trial is to test the safety and potential benefit...
Show More Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Learn More & Join Trial
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma PHASE1 This is a single-center, non-randomized study to evaluate the safety and ef...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma PHASE1 This study is a single-armed, open-label, multicenter Phase 1/2 study to ev...
Show More Location
Institute of Science Tokyo Hospital
Learn More & Join Trial
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia PHASE2 This is a single-arm, open-label study to evaluate the efficacy and safety ...
Show More Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma EARLY_PHASE1 The goal of this clinical trial is to study the feasibility and efficacy of...
Show More Location
Shanghai Changzheng Hospital
Learn More & Join Trial
C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy PHASE2 This Phase 2, multicenter, open-label study will evaluate the safety and ef...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM PHASE1 The goal of this clinical trial is to study the feasibility and efficacy of...
Show More Location
Department of Hematology ,Fudan University Zhongshan Hospital
Learn More & Join Trial